Discovery, Development, and Regulatory Strategy for Biologics and ADCs in Oncology and Immunology
Program | |
8:00 a.m. | Registration / Continental Breakfast / Vendor Exhibit |
8:45 a.m. | Introductory Remarks
Arian Emami Riedmaier, PhD; Chair, NJ DMDG |
9:00 a.m. | The Evolution of First-in-Human Dose Selection for Biologics in Oncology and Beyond
Haiqing Wang, PhD; Senior Director, DMPK, Alnylam |
9:45 a.m. | Mutants, Loners and Bad Influences (Systems Model of KRAS Pathway Describing Mechanism of Response in G13D CRC)
Edward Stites, MD, PhD; Associate Professor of Laboratory Medicine and Pathology, Yale School of Medicine |
10:30 a.m. | Vendor Exhibit & Coffee Break |
11:15 a.m. | Mitochondrial Bioenergetic Health Index as a Biomarker for Kidney Injury
Kiran Deshpande; PhD Candidate, Ernest Mario School of Pharmacy Rutgers, New Brunswick, NJ |
11:45 p.m. | Vendor Exhibit & Lunch |
12:45 p.m. | Immunogenicity Risk Assessments and Bioanalytical Strategy for IND Enabling Studies for Complex Biologics
Sanjay Dholakiya, PhD; Principal Scientist, BMS |
1:30 p.m. | Developing Effective Drug Development Strategies for Biologics
Samuel Chuang, PhD; Senior Director, Scientific Advisory Services, Charles River |
2:15 p.m. | Vendor Exhibit & Coffee Break |
2:30 p.m. | ADCs as Therapeutic Options: History, Resurgence and DXd Based ADCs from DSI
Tushar Garimella, PhD; Executive Director, Clinical Pharmacology, Daiichi-Sankyo |
3:15 p.m. | Medicilon Strategy & Experience for Dual Filing of ADC IND to US FDA & China NMPA
Chunlin Chen, PhD; CEO and Founder, Medicilon USA Corp. |
4:00 p.m. | Program close |
Registration information
- Early-bird fee (prior to March 1, 2024) is $125. Pre-registration after the early-bird date is $150. We are also offering one free attendee for every five that are pre-registered from the same companyRegistration fee at the door is $200
- Registration fee for students and postdocs is $10 and $50 for faculty
- Registration is free for unemployed attendees
- If feasible, please plan to pre-register as a group, as coordinated by a member of the NJACS DMDG steering committee from your organization (see list on the following page)
- If you have no DMDG member at your company, please contact Arian Emami Riedmaier (arian.emamiriedmaier@certara.com) or Keroles Nakhla (keroles.nakhla@novartis.com) for registration
- Payments by personal or company checks or credit cards or registration on this site
Checks should be made payable to: NJ Drug Metabolism Discussion Group. Or please register and pay on this site.
Exhibitors
Please contact Li Yu (liyu.pharmaconsulting@gmail.com) for information concerning exhibits